Media Room

Oligonucleotides

Therapeutic oligonucleotides can be used to treat different types of diseases by modulating gene expression or protein function. Learn more.

Oligonucleotides for Therapeutics

Therapeutic Oligonucleotides Overview

Therapeutics oligonucleotides (oligos) have emerged as an area of particular interest and promise in biopharmaceutical development because of their potential to treat a wide range of diseases. These oligos can range in size, sequence complexity, and overall modifications. Synthetic oligonucleotide therapeutics, such as antisense oligonucleotides (ASOs) and small interfering RNAs (si-RNAs), require thorough analysis to establish intended purity and quality. 
 


Agilent Solutions

Advance Your Lead Oligonucleotide from Discovery to Market - Invest in a proven superior solution, services provider offering multi-application capabilities with a diverse compliant ready portfolio solution and world-class innovation to enable cost-effective manufacturing of commercial-scale quantities of synthetic oligonucleotides.


AGILENT OLIGONUCLEOTIDES END-TO-END WORKFLOW SOLUTIONS


Oligo Purity Analysis   |   Oligo Target Plus Impurity Analysis   |   Oligo Sequence Confirmation   |   Oligo Purification   |   Oligo Raw Material Identification   |   Trace Elemental Impurities   |   Residual Solvent Analysis   |   Oligo API Manufacturing


AGILENT OLIGONUCLEOTIDES WORKFLOW PRODUCTS